Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 8:8:229.
doi: 10.3389/fncel.2014.00229. eCollection 2014.

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling

Cristina Limatola  1 , Richard M Ransohoff  2
Affiliations
Review

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling

Cristina Limatola et al. Front Cell Neurosci. .

Abstract

Since the initial cloning of fractalkine/CX3CL1, it was proposed that the only known member of the CX3C or δ subfamily of chemotactic cytokines could play some significant role in the nervous system, due to its high expression on neurons. The pivotal description of the localization of the unique CX3CL1 receptor, CX3CR1, on microglial cells, firmed up by the generation of cx3cr1(GFP/GFP) mice, opened the road to the hypothesis of some specific key interactions between microglia and neurons mediated by this pair. This expectation has been indeed supported by recent exciting evidence indicating that CX3CL1-mediated microglia-neuron interaction modulates basic physiological activities during development, adulthood and aging, including: synaptic pruning; promoting survival of neurons and neural precursors; modulating synaptic transmission and plasticity; enhancing synapse and network maturation; and facilitating the establishment of neuropathic pain circuits. Beyond playing such fascinating roles in physiological conditions, CX3CL1 signaling has been implicated in different neuropathologies. Early papers demonstrated that the levels of CX3CL1 may be modulated by various toxic stimuli in vitro and that CX3CL1 signaling is positively or negatively regulated in EAE and MS, in HIV infection and LPS challenge, in epilepsy, in brain tumors, and in other neuropathologies. In this review we focus on the experimental evidence of CX3CL1 involvement in neuroprotection and survey the common molecular and cellular mechanisms described in different brain diseases.

Keywords: CX3CL1; CX3CR1; microglia; neurotoxicity; signaling.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Allan S. M., Tyrrell P. J., Rothwell N. J. (2005). Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5 629–640 10.1038/nri1664 - DOI - PubMed
    1. Arnoux I., Hoshiko M., Mandavy L., Avignone E., Yamamoto N., Audinat E. (2013). Adaptive phenotype of microglial cells during the normal postnatal development of the somatosensory “Barrel” cortex. Glia 61 1582–1594 10.1002/glia.22503 - DOI - PubMed
    1. Bachstetter A. D., Morganti J. M., Jernberg J., Schlunk A., Mitchell S. H., Brewster K. W., et al. (2011). Fractalkine and CX3CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol. Aging 32 2030–2044 10.1016/j.neurobiolaging.2009.11.022 - DOI - PMC - PubMed
    1. Bertollini C., Ragozzino D., Gross C., Limatola C., Eusebi F. (2006). Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacol. 51 816–821 10.1016/j.neuropharm.2006.05.027 - DOI - PubMed
    1. Bhaskar K., Konerth M., Kokiko-Cochran O. N., Cardona A., Ransohoff R. M., Lamb B. T. (2010). Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68 19–31 10.1016/j.neuron.2010.08.023 - DOI - PMC - PubMed